Translating microarray data for diagnostic testing in childhood leukaemia

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Hoffmann, Katrin ^a   Firth, Martin J ^a   Beesley, Alex H ^a   de Klerk, Nicholas H ^a   Kees, Ursula R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; TRANSCRIPTION FACTOR E2A;

ACCURACY; ALGORITHM; ARTICLE; CANCER RESEARCH; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME ANALYSIS; CLINICAL LABORATORY; COHORT ANALYSIS; CONTROLLED STUDY; DECISION THEORY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; FEASIBILITY STUDY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEARNING; MICROARRAY ANALYSIS; PREDICTION; PUBLISHING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARDIZATION; SYSTEMATIC REVIEW; VALIDATION STUDY;

CELL LINE, TUMOR; COHORT STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN ARRAY ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33750062866     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-229     Document Type: Article

References (45)

1. Greaves M: Childhood leukaemia. Bmj 2002, 324(7332):283-287.
2. Carroll WL, Bhojwani D, Min DJ, Raetz E, Relling M, Davies S, Downing JR, Willman CL, Reed JC: Pediatric acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program) 2003:102-131.
3. Pui CH, Relling MV, Downing JR: Acute lymphoblastic leukemia. N Engl J Med 2004, 350(15):1535-1548.
4. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996, 14(1):18-24.
5. Rubnitz JE, Pui CH: Molecular diagnostics in the treatment of leukemia. Curr Opin Hematol 1999, 6(4):229-235.
6. Martinez-Climent JA: Molecular cytogenetics of childhood hematological malignancies. Leukemia 1997, 11(12):1999-2021.
7. Harrison CJ: The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia. Blood Rev 2001, 15(1):49-59.
8. Harrison CJ, Martineau M, Secker-Walker LM: The Leukaemia Research Fund/ United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management. Br J Haematol 2001, 113(1):3-10.
9. Mrozek K, Heerema NA, Bloomfield CD: Cytogenetics in acute leukemia. Blood Rev 2004, 18(2):115-136.
10. Golub TP, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286(5439):531-537.
11. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TP, Korsmeyer SJ: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002, 30(1):41-47.
12. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, Behm FG, Pui CH, Downing JR, Gilliland DG, Lander ES, Golub TP, Look AT: Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002, 1:75.
13. Yeoh EJRMESSAWWKPDMRBFGRSCRMVPACCCDWDZXLJLHP-CHEWENCWLDJR: Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002, 1:133-143.
14. Ross ME, Zhou X, Song G, Shurtleff SA, Girtman K, Williams WK, Liu HC, Mahfouz R, Raimondi SC, Lenny N, Patel A, Downing JR: Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 2003, 102(8):2951-2959.
15. Yagi T, Morimoto A, Eguchi M, Hibi S, Sako M, Ishii E, Mizutani S, Imashuku S, Ohki M, Ichikawa H: Identification of a gene expression signature associated with prognosis of pediatric AML. Blood 2003, 102(5):1849-1856.
16. Ross ME, Mahfouz R, Onciu M, Liu HC, Zhou X, Song G, Shurtleff SA, Pounds S, Cheng C, Ma J, Ribeiro RC, Rubnitz JE, Girtman K, Williams WK, Raimondi SC, Liang DC, Shih LY, Pui CH, Downing JR: Gene expression profiling of pediatric acute myelogenous leukemia. Blood 2004, 104(12):3679-3687.
17. Kees UR, Ford J, Watson M, Murch A, Ringner M, Walker RL, Meltzer P: Gene expression profiles in a panel of childhood leukemia cell lines mirror critical features of the disease. Mol Cancer Ther 2003, 2(7):671-677.
18. Hoffmann K, Firth MJ, Freitas JR, de Klerk NH, Kees UR: Gene expression levels in small specimens from patients detected using oligonucleotide arrays. Mol Biotechnol 2005, 29(1):31-38.
19. Ihaka RGR: R: a language for data analysis and graphics. Journal of Computational and Graphical Statistics 1996, 5:299-314.
20. Irizarry RAHBCFBBYDAKSUSTP: Exploration, normalization and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
21. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31(4):e15.
22. Dallas PB, Gottardo NG, Firth MJ, Beesley AH, Hoffmann K, Terry PA, Freitas JR, Boag JM, Cummings AJ, Kees UR: Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate? BMC Genomics 2005, 6(1):59.
23. Zhang H, Yu CY, Singer B, Xiong M: Recursive partitioning for tumor classification with gene expression microarray data. Proc Natl Acad Sci U S A 2001, 98(12):6730-6735.
24. Beesley AH, Cummings AJ, Freitas JR, Hoffmann K, Firth MJ, Ford J, de Klerk NH, Kees UR: The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure. Br J Haematol 2005, 131(4):447-456.
25. Ambroise C, McLachlan GJ: Selection bias in gene extraction on the basis of microarray gene- expression data. Proc Natl Acad Sci U S A 2002, 99(10):6562-6566.
26. Simon R. Radmacher MD. Dobbin K. McShane LM: Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 2003, 95(1):14-18.
27. Zhang H, Yu CY, Singer B: Cell and tumor classification using gene expression data. construction of forests. Proc Natl Acad Sci U S A 2003, 100(7):4168-4172.
28. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC, Golub TR: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002, 8(1):68-74.
29. Willenbrock H, Juncker AS, Schmiegelow K, Knudsen S, Ryder LP: Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays. Leukemia 2004, 18(7):1270-1277.
30. Ebert BL, Golub TR: Genomic approaches to hematologic malignancies. Blood 2004, 104(4):923-932.
31. Fu LM, Fu-Liu CS: Multi-class cancer subtype classification based on gene expression signatures with reliability analysis. FEBS Lett 2004, 561(1-3):186-190.
32. Hoffman EP, The Tumor Analysis Best Practices Working Group: Expression profiling - best practices for data generation and interpretation in clinical trials. Nat Rev Genet 2004, 5(3):229-237.
33. Fusaro G, Dasgupta P, Rastogi S, Joshi B, Chellappan S: Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apaptotic signaling. The Journal of Biological Chemistry 2003, 278(48):47853-47861.
34. Smith EM, Gisler R, Sigvardsson M: Cloning and characterization of a promoter flanking the early B cell factor (EBF) gene indicates roles for E-proteins and autoregulation in the control of EBF expression. J Immunol 2002, 169(1):261-270.
35. McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C: Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia. Proc Natl Acad Sci U S A 1999, 96(20):11464-11469.
36. Gunther EC, Stone DJ, Gerwien RW, Bento P, Heyes MP: Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc Natl Acad Sci U S A 2003, 100(16):9608-9613.
37. Cheok MH, Yang W, Pui CH, Downing JR, Cheng C, Naeve CW, Relling MV, Evans WE: Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nat Genet 2003, 34(1):85-90.
38. Moos PJ, Raetz EA, Carlson MA, Szabo A, Smith FE, Willman C, Wei Q, Hunger SP, Carroll WL: Identification of gene expression profiles that segregate patients with childhood leukemia. Clin Cancer Res 2002, 8(10):3118-3130.
39. Tsutsumi S, Taketani T, Nishimura K, Ge X, Taki T, Sugita K, Ishii E, Hanada R, Ohki M, Aburatani H, Hayashi Y: Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements. Cancer Res 2003, 63(16):4882-4887.
40. Rubnitz JE, Pui CH: Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia. Cancer Treat Rev 2003, 29(1):31-44.
41. Maloney KW, Shuster JJ, Murphy S, Pullen J, Camitta BA: Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994. Leukemia 2000, 14(12):2276-2285.
42. Kersey JH: Fifty years of studies of the biology and therapy of childhood leukemia. Blood 1997, 90(11):4243-4251.
43. Gaynon PS, Trigg ME, Heerema NA, Sensel MG, Sather HN, Hammond GD, Bleyer WA: Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia 2000, 14(12):2223-2233.
44. Marshall E: Getting the noise out of gene arrays. Science 2004, 306(5696):630-631.
45. Michiels S, Koscielny S, Hill C: Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005, 365(9458):488-492.